| 12/13/2021 |
World Immuno-Oncology Diagnostics Markets, 2022-2026: Shifting Role of Diagnostics, Multiplexing and Foundation One, The Disruption Dynamic, The Race for Biomarkers, The Next Five Years |
PR Newswire |
DUBLIN , Dec. The "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, 2022 - 2026" report has been added to ResearchAndMarkets.com's offering.Diagnostics, companion diagnostics, is driving the success of Immuno-oncology Therapeutics. An entire new segment of the diagnostics industry is being created and its not a small segment either. It promises to grow dramatically. Histology, genomics and liquid biopsy are converging. A complicated network of pharmaceutical ... |
| 12/13/2021 |
World Immuno-Oncology Diagnostics Markets, 2022-2026: Shifting Role of Diagnostics, Multiplexing and Foundation One, The Disruption Dynamic, The Race for Biomarkers, The Next Five Years |
continentalnewsshow.com |
World Immuno-Oncology Diagnostics Markets, 2022-2026: Shifting Role of Diagnostics, Multiplexing and Foundation One, The Disruption Dynamic, The Race for Biomarkers, The Next Five YearsDUBLIN, Dec. 13, 2021 /PRNewswire/ — The “Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, 2022 – 2026″…DUBLIN, Dec. 13, 2021 /PRNewswire/ — The “Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, 2022 – ... |
| 12/6/2021 |
Global Diagnostics Imaging Market 2021-2027 - Opportunities in the Adoption of AI and Analytics, Use of Blockchain & Contract-based Solutions - ResearchAndMarkets.com |
Business Wire |
DUBLIN--(BUSINESS WIRE)--Dec 6, 2021--The "Global Diagnostics Imaging Market (2021-2027) By Product, Application, End Users and Geography, Impact of Covid-19, Ansoff Analysis" report has been added to ResearchAndMarkets.com 's offering.Diagnostics Imaging includes variety of non-invasive methods for scanning and examining the body for diagnostics and treatment purposes. The imaging techniques are also used for post-treatment check-ups.The Global Diagnostics Imaging Market is estimated ... |
| 12/3/2021 |
OrigiMed announced its strategic partnership with Janssen to develop clinical innovative solutions driven by data science |
PR Newswire |
... Ping Zhao , Senior Vice President of OrigiMed for Pharmaceutical Cooperation attended the Janssen - OrigiMed MoU on Strategic Collaboration Signing Ceremony. Najat Khan , PhD, Chief Data Science Officer, Janssen R&D, Zach Boyd , PhD, Head Oncology Diagnostics , Janssen R&D also expressed their sincere wishes and expectations to the audience by VCR.MoU Signing Ceremony Leveraging the power of real-world evidence, both parties will jointly explore to optimize clinical trials ... |
| 10/19/2021 |
Facilities Technician – INVIVOSCRIBE INC – San Diego, CA |
medacura.com |
Invivoscribe is an industry pioneer in oncology diagnostics , dedicated to improving the standard of global healthcare for over 25 years. Headquartered in sunny San Diego, California with locations across the world, we offer a comprehensive portfolio of products and services. We work with key collaborators to develop molecular assays, reagents, controls and bioinformatics tools under ISO 13485 design control that are used in over 160 countries. For 25 years, we ... |
| 10/12/2021 |
GeneCentric Therapeutics Collaborates with Labcorp to Develop Novel RNA-Based Oncology Diagnostics | Business Wire |
Business Wire |
... broader patient population that may benefit from targeted or immunotherapy.“Our latest strategic collaboration with GeneCentric will draw upon their industry-leading RNA-based signatures and help facilitate the creation of better tools for oncology diagnostics, drug development and patient care,” said Steven Anderson, Ph.D., senior vice president and chief scientific officer at Labcorp Drug Development. “The new diagnostics developed through this arrangement will further our goal of enabling ... |
| 10/12/2021 |
GeneCentric Therapeutics Collaborates with Labcorp to Develop Novel RNA-Based Oncology Diagnostics |
Yahoo News |
... population that may benefit from targeted or immunotherapy.Story continues "Our latest strategic collaboration with GeneCentric will draw upon their industry-leading RNA-based signatures and help facilitate the creation of better tools for oncology diagnostics, drug development and patient care," said Steven Anderson, Ph.D., senior vice president and chief scientific officer at Labcorp Drug Development. "The new diagnostics developed through this arrangement will further our goal of enabling physicians ... |
| 10/7/2021 |
Oncocyte Appoints Gisela A. Paulsen as Chief Operating Officer |
Globe Newswire |
... pharmaceutical and diagnostics companies.“We believe that Gisela’s years of driving focused, strategic growth will be instrumental in strengthening and expanding our existing capabilities and maximizing new opportunities as a leader in precision oncology diagnostics and monitoring,” said Ron Andrews, President and Chief Executive Officer of Oncocyte. “I trust that her diverse experience will have an immediate impact, and that she will bring a solid operational skill set ... |
| 10/4/2021 |
Global $892 Mn Clinical Oncology Next Generation Sequencing Markets to 2028 by Technology (WGS, WES) & Application (Screening, Companion Diagnostics) |
Globe Newswire |
... for the analysis of liquid biopsy samples. This leads to efficient molecular profiling of tumors, which, in turn, facilitates real-time, non-invasive monitoring of tumors. Moreover, a rise in market competitiveness, growth in oncology diagnostics spending, and increasing research activities to develop solutions that can potentially be used for clinical oncology drive market progression. For instance, in January 2021, Spectrum Solutions, LLC collaborated with the UCLA School of Dentistry ... |
| 10/4/2021 |
Global Clinical Oncology Next Generation Sequencing Market Analysis Report 2021 - ResearchAndMarkets.com |
Yahoo News |
... for the analysis of liquid biopsy samples. This leads to efficient molecular profiling of tumors, which, in turn, facilitates real-time, non-invasive monitoring of tumors.Moreover, a rise in market competitiveness, growth in oncology diagnostics spending, and increasing research activities to develop solutions that can potentially be used for clinical oncology drive market progression. For instance, in January 2021, Spectrum Solutions, LLC collaborated with the UCLA School of Dentistry ... |
| 10/4/2021 |
Global Clinical Oncology Next Generation Sequencing Market Analysis Report 2021 - ResearchAndMarkets.com |
Business Wire |
... for the analysis of liquid biopsy samples. This leads to efficient molecular profiling of tumors, which, in turn, facilitates real-time, non-invasive monitoring of tumors. Moreover, a rise in market competitiveness, growth in oncology diagnostics spending, and increasing research activities to develop solutions that can potentially be used for clinical oncology drive market progression. For instance, in January 2021, Spectrum Solutions, LLC collaborated with the UCLA School of Dentistry ... |
| 10/4/2021 |
Global Clinical Oncology Next Generation Sequencing Markets 2021-2028 - Rise in Competition Amongst Prominent Market Entities |
Yahoo News |
... for the analysis of liquid biopsy samples. This leads to efficient molecular profiling of tumors, which, in turn, facilitates real-time, non-invasive monitoring of tumors.Moreover, a rise in market competitiveness, growth in oncology diagnostics spending, and increasing research activities to develop solutions that can potentially be used for clinical oncology drive market progression. For instance, in January 2021 , Spectrum Solutions, LLC collaborated with the UCLA School of Dentistry ... |
| 10/4/2021 |
Global Clinical Oncology Next Generation Sequencing Market Analysis Report 2021 – ResearchAndMarkets.com | Financial Buzz |
financialbuzz.com |
... for the analysis of liquid biopsy samples. This leads to efficient molecular profiling of tumors, which, in turn, facilitates real-time, non-invasive monitoring of tumors.Moreover, a rise in market competitiveness, growth in oncology diagnostics spending, and increasing research activities to develop solutions that can potentially be used for clinical oncology drive market progression. For instance, in January 2021, Spectrum Solutions, LLC collaborated with the UCLA School of Dentistry ... |
| 9/30/2021 |
DNA diagnostic market is expected to grow at a CAGR of 9%-12% by 2026 – An exclusive market research report by Lucintel |
carsoncityheadlines.com |
... research report by Lucintel Lucintel’s latest market report analyzed that DNA diagnostic provides attractive opportunities in applications, such as pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/p450 effects. The DNA diagnostic market is expected to grow at a CAGR of 9%-12%. In this market, instruments are the largest segment ... |
| 9/29/2021 |
Deer Park Tribune |
dptribune.com |
... 2025 by product (instruments, reagents, and service & software), technology (microarray based, PCR based, In-situ hybridization, NGS DNA diagnosis), application (pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/P450 effects), & region Lucintel's latest market report analyzed that DNA diagnostic provides attractive opportunities in applications, such as pre-natal DNA carrier screening, pre ... |
| 9/29/2021 |
DNA diagnostic market is expected to grow at a CAGR of 9%-12% by 2026 - An exclusive market research report by Lucintel |
blogspot.com |
... 2025 by product (instruments, reagents, and service & software), technology (microarray based, PCR based, In-situ hybridization, NGS DNA diagnosis), application (pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/P450 effects), & region Lucintel's latest market report analyzed that DNA diagnostic provides attractive opportunities in applications, such as pre-natal DNA carrier screening, pre ... |
| 9/29/2021 |
DNA diagnostic market is expected to grow at a CAGR of 9%-12% by 2026 – An exclusive market research report by Lucintel |
salemnewsheadlines.com |
Lucintel’s latest market report analyzed that DNA diagnostic provides attractive opportunities in applications, such as pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/p450 effects. The DNA diagnostic market is expected to grow at a CAGR of 9%-12%. In this market, instruments are the largest segment by product, whereas infectious ... |
| 9/29/2021 |
DNA diagnostic market is expected to grow at a CAGR of 9%-12% by 2026 – An exclusive market research report by Lucintel |
newslighthouse.com |
Lucintel’s latest market report analyzed that DNA diagnostic provides attractive opportunities in applications, such as pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/p450 effects. The DNA diagnostic market is expected to grow at a CAGR of 9%-12%. In this market, instruments are the largest segment by product, whereas infectious ... |
| 9/29/2021 |
DNA diagnostic market is expected to grow at a CAGR of 9%-12% by 2026 – An exclusive market research report by Lucintel |
worldsharemarketlive.com |
Lucintel’s latest market report analyzed that DNA diagnostic provides attractive opportunities in applications, such as pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/p450 effects. The DNA diagnostic market is expected to grow at a CAGR of 9%-12%. In this market, instruments are the largest segment by product, whereas infectious ... |
| 9/28/2021 |
Global Immuno-Oncology Diagnostics Market Report 2021: COVID-19 Changes the Focus of Research - Forecast to 2025 |
Globe Newswire |
Dublin, Sept. 28, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Diagnostics Market Forecasts with COVID-19 Impact and Updates, Including Executive/Consultant Guides and Customized Forecasting/Analysis - 2021 to 2025" report has been added to ResearchAndMarkets.com's offering. Revolution in cancer therapy to be driven by new diagnostics. Histology, genomics and liquid biopsy converge. COVID-19 changes the focus of research. This is a complex area but this readable report will bring ... |